Azithromycin

Min.Order / FOB Price:Get Latest Price

100 Kilogram	Negotiable

100 Kilogram

Negotiable

Azithromycin price Azithromycin CAS 83905-01-5 Azithromycin supplier in China

Appearance:white crystalline powder
Application:Azithromycin is a semi-synthetic, ring-expanded erythromycin, produced by a Beckmann rearrangement of erythromycin oxime and reduction to the imine ether, followed by reductive methylation. Azithromyc
PackAge:25kg/drum;200kg/drum as per your request
ProductionCapacity:1|Metric Ton|Month
Storage:Stored in cool, dry and ventilation place; Away from fire and heat
Transportation:by courier door to door or by sea

Superior quality, moderate price & quick delivery.

Azithromycin Chemical Properties

mp	113-115°C
storage temp.	Store at -20°C
Stability:	Stable. Incompatible with strong oxidizing agents.
CAS DataBase Reference	83905-01-5(CAS DataBase Reference)
EPA Substance Registry System	1-Oxa-6-azacyclopentadecan- 15-one, 13-[(2,6-dideoxy-3-C-methyl- 3-O-methyl-.alpha.-L-ribo- hexopyranosyl)oxy]-2-ethyl- 3,4,10-trihydroxy-3,5,6,8, 10,12,14-heptamethyl-11-[[ 3,4,6-trideoxy-3-(dimethylamino)-. beta.-D-xylo-hexopyranosyl] oxy]-, (2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-(83905-01-5)

Safety Information

MSDS Information

Provider	Language
Azithromycin	English

Azithromycin Usage And Synthesis

Chemical Properties	White Crystalline Powder
Usage	Labelled Azithromycin, a semi-synthetic macrolide antibiotic; related to Erythromycin A. Antibacterial.
Usage	Azithromycin is a semi-synthetic, ring-expanded erythromycin, produced by a Beckmann rearrangement of erythromycin oxime and reduction to the imine ether, followed by reductive methylation. Azithromycin was the first of the azalides and was designed to improve stability and biological half-life of erythromycin A, as well as improve activity against Gram negative bacteria. Since its discovery in 1980 by Djokic and co-workers, azithromycin has enjoyed considerable therapeutic success.
Biological Activity	Macrolide antibiotic. Inhibits 50S ribosomal subunit formation and elongation at transpeptidation step in gram-positive and gram-negative organisms. Orally active with improved pharmacokinetics over erythromycin in mouse models.